BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5-11 Years of Age : A Test Negative Design
© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society..
In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47-69] <3 months post-dose-two and 28% [8-43] after ≥3 months. A booster improved protection to 77% [53-88].
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Journal of the Pediatric Infectious Diseases Society - 12(2023), 3 vom: 18. Apr., Seite 177-179 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tartof, Sara Y [VerfasserIn] |
---|
Links: |
---|
Themen: |
BNT162 Vaccine |
---|
Anmerkungen: |
Date Completed 20.04.2023 Date Revised 21.04.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/jpids/piad005 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352254793 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352254793 | ||
003 | DE-627 | ||
005 | 20231226053309.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/jpids/piad005 |2 doi | |
028 | 5 | 2 | |a pubmed24n1174.xml |
035 | |a (DE-627)NLM352254793 | ||
035 | |a (NLM)36715070 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tartof, Sara Y |e verfasserin |4 aut | |
245 | 1 | 0 | |a BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5-11 Years of Age |b A Test Negative Design |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.04.2023 | ||
500 | |a Date Revised 21.04.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. | ||
520 | |a In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47-69] <3 months post-dose-two and 28% [8-43] after ≥3 months. A booster improved protection to 77% [53-88] | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a BNT162b2 | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Kaiser Permanente | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a United States | |
650 | 4 | |a booster | |
650 | 4 | |a delta | |
650 | 4 | |a effectiveness | |
650 | 4 | |a omicron | |
650 | 4 | |a pediatric | |
650 | 4 | |a real-world | |
650 | 4 | |a test-negative | |
650 | 7 | |a BNT162 Vaccine |2 NLM | |
700 | 1 | |a Frankland, Timothy B |e verfasserin |4 aut | |
700 | 1 | |a Puzniak, Laura |e verfasserin |4 aut | |
700 | 1 | |a Slezak, Jeff M |e verfasserin |4 aut | |
700 | 1 | |a Hong, Vennis |e verfasserin |4 aut | |
700 | 1 | |a Takhar, Harpreet |e verfasserin |4 aut | |
700 | 1 | |a Ogun, Oluwaseye A |e verfasserin |4 aut | |
700 | 1 | |a Simmons, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Xie, Fagen |e verfasserin |4 aut | |
700 | 1 | |a Zamparo, Joann |e verfasserin |4 aut | |
700 | 1 | |a Ackerson, Bradley K |e verfasserin |4 aut | |
700 | 1 | |a Jodar, Luis |e verfasserin |4 aut | |
700 | 1 | |a McLaughlin, John M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the Pediatric Infectious Diseases Society |d 2012 |g 12(2023), 3 vom: 18. Apr., Seite 177-179 |w (DE-627)NLM227436326 |x 2048-7207 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g day:18 |g month:04 |g pages:177-179 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/jpids/piad005 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2023 |e 3 |b 18 |c 04 |h 177-179 |